Search research articles
Contact Us
Filters
Showing results (141-150 of 418) with videos related to
Page
of 42
Sort By:
The Journal of Investigative Dermatology
|
March 20, 2015
MITF Modulates Therapeutic Resistance through EGFR Signaling
Zhenyu Ji, Yiyin Erin Chen, Raj Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2011
Phase I, dose-escalation trial of the oral cyclin-dependent kinase 4/6 inhibitor PD 0332991, administered using a 21-day schedule in patients with advanced cancer
Keith T Flaherty, Patricia M Lorusso, Angela Demichele, et al.
Molecular Cancer Therapeutics
|
June 21, 2023
Targeting Upregulated cIAP2 in SOX10-Deficient Drug Tolerant Melanoma
McKenna Q Glasheen, Signe Caksa, Amelia G Young, et al.
Pigment Cell & Melanoma Research
|
February 1, 2017
MicroRNA-125a promotes resistance to BRAF inhibitors through suppression of the intrinsic apoptotic pathway
Lisa Koetz-Ploch, Douglas Hanniford, Igor Dolgalev, et al.
Cancer Research
|
July 18, 2008
Identification of a novel subgroup of melanomas with KIT/cyclin-dependent kinase-4 overexpression
Keiran S M Smalley, Rooha Contractor, Thiennga K Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2005
Phase I trial of combretastatin a-4 phosphate with carboplatin
Joshua H Bilenker, Keith T Flaherty, Mark Rosen, et al.
Cancer Discovery
|
December 28, 2014
EPHA2 is a mediator of vemurafenib resistance and a novel therapeutic target in melanoma
Benchun Miao, Zhenyu Ji, Li Tan, et al.
Pigment Cell & Melanoma Research
|
November 29, 2011
Meeting report from the 2011 International Melanoma Congress, Tampa, Florida
Keiran S M Smalley, Andrew E Aplin, Keith T Flaherty, et al.
Oncoimmunology
|
November 20, 2013
BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes
Zachary A Cooper, Dennie T Frederick, Vikram R Juneja, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 11, 2008
Phase II trial of sorafenib in advanced thyroid cancer
Vandana Gupta-Abramson, Andrea B Troxel, Anoma Nellore, et al.
Page
of 42
Search research articles
Search
Showing results (141-150 of 418) with videos related to
Sort By:
Page
of 42
The Journal of Investigative Dermatology
|
March 20, 2015
MITF Modulates Therapeutic Resistance through EGFR Signaling
Zhenyu Ji, Yiyin Erin Chen, Raj Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2011
Phase I, dose-escalation trial of the oral cyclin-dependent kinase 4/6 inhibitor PD 0332991, administered using a 21-day schedule in patients with advanced cancer
Keith T Flaherty, Patricia M Lorusso, Angela Demichele, et al.
Molecular Cancer Therapeutics
|
June 21, 2023
Targeting Upregulated cIAP2 in SOX10-Deficient Drug Tolerant Melanoma
McKenna Q Glasheen, Signe Caksa, Amelia G Young, et al.
Pigment Cell & Melanoma Research
|
February 1, 2017
MicroRNA-125a promotes resistance to BRAF inhibitors through suppression of the intrinsic apoptotic pathway
Lisa Koetz-Ploch, Douglas Hanniford, Igor Dolgalev, et al.
Cancer Research
|
July 18, 2008
Identification of a novel subgroup of melanomas with KIT/cyclin-dependent kinase-4 overexpression
Keiran S M Smalley, Rooha Contractor, Thiennga K Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2005
Phase I trial of combretastatin a-4 phosphate with carboplatin
Joshua H Bilenker, Keith T Flaherty, Mark Rosen, et al.
Cancer Discovery
|
December 28, 2014
EPHA2 is a mediator of vemurafenib resistance and a novel therapeutic target in melanoma
Benchun Miao, Zhenyu Ji, Li Tan, et al.
Pigment Cell & Melanoma Research
|
November 29, 2011
Meeting report from the 2011 International Melanoma Congress, Tampa, Florida
Keiran S M Smalley, Andrew E Aplin, Keith T Flaherty, et al.
Oncoimmunology
|
November 20, 2013
BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes
Zachary A Cooper, Dennie T Frederick, Vikram R Juneja, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 11, 2008
Phase II trial of sorafenib in advanced thyroid cancer
Vandana Gupta-Abramson, Andrea B Troxel, Anoma Nellore, et al.
Page
of 42